Page last updated: 2024-10-29

avapro and Multiple Myeloma

avapro has been researched along with Multiple Myeloma in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sala, F1
Marangon, E1
Bagnati, R1
Livi, V1
Cereda, R1
D'Incalci, M1
Zucchetti, M1

Other Studies

1 other study available for avapro and Multiple Myeloma

ArticleYear
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study.
    Journal of mass spectrometry : JMS, 2010, Volume: 45, Issue:11

    Topics: Acetonitriles; Biphenyl Compounds; Boronic Acids; Chromatography, High Pressure Liquid; Clinical Tri

2010